PGNX:
Analysis & Opinions
-
November 12, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted third quarter earnings of 95 cents per share, well above the Zacks ...
-
September 10, 2012
The US Food and Drug Administration (FDA) recently informed Salix Pharmaceuticals, Ltd. (SLXP) that it is still ...
-
August 13, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted second quarter earnings of 79 cents per share, well above the Zacks ...
-
July 11, 2012
Theravance Inc. (THRX) recently announced positive top-line results on TD-1211 from a phase IIb study, 0084. TD-1211 ...
-
May 08, 2012
Salix Pharmaceuticals, Ltd. (SLXP) posted first quarter earnings of 67 cents per share, well above the Zacks ...
-
May 07, 2012
Salix Pharmaceuticals, Ltd. (SLXP) is facing a delay where the approval of two of its pipeline candidates is ...
-
January 18, 2012
Salix is a great candidate for growth investors.
-
March 03, 2011
Salix has taken another blow from the FDA, but seems too cheap given its prospects.
